156 related articles for article (PubMed ID: 35921902)
1. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
Li D; Zhang Z
Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Tripartite Motif-Containing Protein 37 (TRIM37) Inhibits the Proliferation and Tumorigenesis in Colorectal Cancer Cells.
Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
Oncol Res; 2017 Jan; 25(1):115-122. PubMed ID: 28081740
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
Zheng Y; Zhang H; Sun H
Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
[TBL] [Abstract][Full Text] [Related]
4. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Liu H; Shi H; Fan Q; Sun X
Tumour Biol; 2016 Aug; 37(8):10161-75. PubMed ID: 26831658
[TBL] [Abstract][Full Text] [Related]
5. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
Qu H; Liu H; Jin Y; Cui Z; Han G
Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
[TBL] [Abstract][Full Text] [Related]
6. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
7. TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment.
Do TT; Yeh CC; Wu GW; Hsu CC; Chang HC; Chen HC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163097
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
9. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
10. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791
[TBL] [Abstract][Full Text] [Related]
11. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway.
Zhu H; Chen Y; Zhang J; Qian C; Qiu W; Shen H; Shen Z
Onco Targets Ther; 2020; 13():5479-5491. PubMed ID: 32606764
[TBL] [Abstract][Full Text] [Related]
14. TRIM37 promoted the growth and migration of the pancreatic cancer cells.
Jiang J; Tian S; Yu C; Chen M; Sun C
Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261
[TBL] [Abstract][Full Text] [Related]
15. CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway.
Gao LN; Hao M; Liu XH; Zhang L; Dong Y; Zhang YF; He XC
J Ovarian Res; 2021 Nov; 14(1):159. PubMed ID: 34789307
[TBL] [Abstract][Full Text] [Related]
16. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
17. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
18. Tumour suppressive function of HUWE1 in thyroid cancer.
Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
J Biosci; 2016 Sep; 41(3):395-405. PubMed ID: 27581931
[TBL] [Abstract][Full Text] [Related]
19. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
Ma N; Zhao Y
Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
[TBL] [Abstract][Full Text] [Related]
20. PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2.
Liu XL; Liu HM; Han N; Li FH; Sun F; Fan DM; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8239-8248. PubMed ID: 31646554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
